MetaCap

Eocene (EOCN) vs PRF Technologies (PRFX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Eocene is the larger company by market cap ($1.9 million vs $1.7 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

EOCN-48.52%PRFX-45.79%
+7%-22%-52%
Oct 7, 20261 yearNov 20, 2026
EOCN-49.71%PRFX-45.86%
+2%-25%-52%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

EOCN versus PRFX key metrics
MetricEOCNPRFX
Share price$1.78$0.4758
Market cap$1.90M$1.66M
1-day change+1.73%-23.68%
EPS (TTM)$-15.21$-4.09
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$17.00K
Net income (latest FY)$-10.31M$-5.02M
Gross margin—-311.76%
Operating margin—-30129.41%
Net margin—-29541.18%
52-week high$10.08$7.95
52-week low$1.75$0.46
Distance from 52-week high-82.34%-94.02%
Analyst consensusnone—
Average volume18.17K228.55K
Shares outstanding1.07M3.50M
Employees36
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Eocene

EOCN stock →

Eocene Ltd. a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications.

Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees

About PRF Technologies

PRFX stock →

PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia.

Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees

EOCN vs PRFX FAQ

Which is bigger, Eocene or PRF Technologies?

Eocene (EOCN) is larger, with a market capitalization of $1.90M compared with $1.66M for PRF Technologies (PRFX).

Are Eocene and PRF Technologies in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons